Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950123-03-005392
Filing Date
2003-05-07
Accepted
2003-05-07 08:12:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 FILED PURSUANT TO RULE 424B3 y83403b3e424b3.txt 424B3 760970
  Complete submission text file 0000950123-03-005392.txt   762553
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B3 | Act: 33 | File No.: 333-103644 | Film No.: 03685116
SIC: 2835 In Vitro & In Vivo Diagnostic Substances